Design Approaches for Current and Future HIV Prevention Efficacy Trials
VIRTUAL WORKSHOP SERIES
October 2020 to May 2021
VIRTUAL WORKSHOP SERIES
October 2020 to May 2021
Hosted by The Global HIV Vaccine Enterprise in partnership with the HIV Vaccine Trials Network, the HIV Prevention Trials Network and and the Forum for Collaborative Research
IF YOU HAVE ALREADY ATTENDED SESSION 1 AND 2 YOU DO NOT NEED TO REGISTER AGAIN,
YOU WILL RECEIVE THE ZOOM REGISTRATION BY EMAIL.
If you are attending for the first time, please register below to get your personal Zoom link on the next page!
HIV prevention is evolving rapidly with the roll out of new tools such as pre-exposure prophylaxis (PrEP) and treatment as prevention making a significant contribution towards controlling the epidemic. As a result, the design and conduct of the next generation of prevention trials is impacted and is further affected by the outcomes of ongoing HIV prevention efficacy trials – including oral and injectable antiretrovirals, passively infused monoclonal antibodies, and HIV vaccines.
This series of virtual workshop aims to continue from the first HIV Prevention Efficacy Trial Designs of the Future symposium, held in November 2018 in Seattle by the Fred Hutch and the NIAID, which led to a series of articles published in Statistical Communications in Infectious Diseases and a viewpoint in The Lancet HIV.
Participants will reflect on more recent advances and challenges within the HIV prevention field and on the rationale and lessons learned for current HIV prevention designs. They will examine novel scientific approaches for establishing efficacy of new biologics in a future where all trial participants have access to effective prevention.
The event will feature a series of online talks given by biostatisticians and clinical trial experts, and will include live panel discussions with clinicians, ethicists, regulators, community members and sponsors.
The programme is designed to accommodate virtual interactions and will offer pre-recorded presentations available online on-demand and live events focused on discussion.
A series of articles, based on the talks given at the symposium, will be published in a selected high-impact journal.
Please share among your network.
More details on each session will be sent out closer to the date.
Date | Event |
27 October 2020 | Live session 1: Current efficacy trial design approaches – Challenges and lessons learned |
Friday 6 November | Live session 2A: Future design approaches for settings where all participants are on active prevention – ARV based prevention |
Wednesday 18 November | Live session 2B: Future design approaches for settings where all participants are on active prevention – Vaccines |
25 February 2021 | Live Session 3A: Novel Scientific Approaches for Establishing Efficacy of New Biologics |
March 2021 | Live session 2C: Future design approaches for settings where all participants are on active prevention – Monoclonal antibodies |
April 2021 | Panel Discussion 3B: Community engagement and involvement in clinical research Regulatory forum organized by the Forum for Collaborative research |
For queries, please contact enterprise@iasociety.org.
The organization of this workshop is supported by a grant from the Bill and Melinda Gates Foundation and the US National Institutes of Health (NIH).
Established in 2003, the Global HIV Vaccine Enterprise (the Enterprise) became a programme of IAS – the International AIDS Society – in 2018. The Enterprise unites stakeholders to share knowledge, foster collaboration, enable solutions and expand support critical to the development of – and future access to – an HIV vaccine.
IAS – the International AIDS Society
Avenue de France 23
CH-1202 Geneva
Switzerland
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
OKLearn moreWe may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to deliver the website, refuseing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.
We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Google reCaptcha Settings:
Vimeo and Youtube video embeds:
You can read about our cookies and privacy settings in detail on our Privacy Policy Page.
Privacy policy